Testing Mitochondrial-Targeted Drugs in iPSC-RPE from Patients with Age-Related Macular Degeneration

Testing Mitochondrial-Targeted Drugs in iPSC-RPE from Patients with Age-Related Macular Degeneration

Age-related macular degeneration (AMD) is the leading cause of blindness in the elderly. No universally effective treatments exist for atrophic or “dry” AMD, which results from loss of the retinal pigment epithelium (RPE) and photoreceptors and accounts for ≈80% of all AMD patients. Prior studies pr...

Full description

Bibliographic Details
Main Authors:	Mara C. Ebeling, Zhaohui Geng, Madilyn R. Stahl, Rebecca J. Kapphahn, Heidi Roehrich, Sandra R. Montezuma, Deborah A. Ferrington, James R. Dutton
Format:	Article
Language:	English
Published:	MDPI AG 2022-01-01
Series:	Pharmaceuticals
Subjects:	human-induced pluripotent stem cells retinal pigment epithelium age-related macular degeneration personalized drug testing
Online Access:	https://www.mdpi.com/1424-8247/15/1/62

Similar Items

Impaired Mitochondrial Function in iPSC-Retinal Pigment Epithelium with the Complement Factor H Polymorphism for Age-Related Macular Degeneration
by: Mara C. Ebeling, et al.
Published: (2021-04-01)

Human iPSC- and Primary-Retinal Pigment Epithelial Cells for Modeling Age-Related Macular Degeneration
by: Cody R. Fisher, et al.
Published: (2022-03-01)

Inflammasome Activation in Retinal Pigment Epithelium from Human Donors with Age-Related Macular Degeneration
by: Mara C. Ebeling, et al.
Published: (2022-06-01)

Altered bioenergetics and enhanced resistance to oxidative stress in human retinal pigment epithelial cells from donors with age-related macular degeneration
by: Deborah A. Ferrington, et al.
Published: (2017-10-01)

Comparison of histologic findings in age-related macular degeneration with RPE flatmount images
by: Qing Zhang, et al.
Published: (2019-02-01)

Improving retinal mitochondrial function as a treatment for age-related macular degeneration
by: Mara C. Ebeling, et al.
Published: (2020-07-01)

iPSC-based treatment of age-related macular degeneration (AMD): The path to success requires more than blind faith
by: Fei Li, et al.
Published: (2017-06-01)

Quantitative Proteomics of Human Retinal Pigment Epithelium Reveals Key Regulators for the Pathogenesis of Age-Related Macular Degeneration
by: Shichen Shen, et al.
Published: (2023-02-01)

Potential of Induced Pluripotent Stem Cells (iPSCs) for Treating Age-Related Macular Degeneration (AMD)
by: Mark Fields, et al.
Published: (2016-12-01)

Advances in the treatment of age-related macular degeneration with induced pluripotent stem cells
by: Yi-Jie Lu, et al.
Published: (2019-10-01)

Differential Expression of Inflammasome-Related Genes in Induced Pluripotent Stem-Cell-Derived Retinal Pigment Epithelial Cells with or without History of Age-Related Macular Degeneration
by: Maria Hytti, et al.
Published: (2021-06-01)

The role of inflammation in age-related macular degeneration
by: Diana Florina Tricorache, et al.
Published: (2023-10-01)

Molecular Mechanisms of Retinal Pigment Epithelium Dysfunction in Age-Related Macular Degeneration
by: Jongmin Kim, et al.
Published: (2021-11-01)

Generation and Differentiation of Induced Pluripotent Stem Cells from Mononuclear Cells in An Age-Related Macular Degeneration Patient
by: Tongmiao Wang, et al.
Published: (2022-12-01)

Cell therapy with hiPSC-derived RPE cells and RPCs prevents visual function loss in a rat model of retinal degeneration
by: Anna Salas, et al.
Published: (2021-03-01)

Long-Term Transplant Effects of iPSC-RPE Monolayer in Immunodeficient RCS Rats
by: Deepthi S. Rajendran Nair, et al.
Published: (2021-10-01)

RPE phagocytic function declines in age-related macular degeneration and is rescued by human umbilical tissue derived cells
by: George Inana, et al.
Published: (2018-03-01)

Review of graft rejection in age-related macular degeneration replacement therapy
by: Xi-Ying Mao, et al.
Published: (2016-02-01)

Metabolomics and Age-Related Macular Degeneration
by: Connor N. Brown, et al.
Published: (2018-12-01)

Where Are We with RPE Replacement Therapy? A Translational Review from the Ophthalmologist Perspective
by: Raffaele Raimondi, et al.
Published: (2022-01-01)

Generation of retinal pigmented epithelium from iPSCs derived from the conjunctiva of donors with and without age related macular degeneration.
by: Zhouhui Geng, et al.
Published: (2017-01-01)

The Expansion of RPE Atrophy after the Inverted ILM Flap Technique for a Chronic Large Macular Hole
by: Hisanori Imai, et al.
Published: (2014-03-01)

Pluripotent Stem Cells in Clinical Cell Transplantation: Focusing on Induced Pluripotent Stem Cell-Derived RPE Cell Therapy in Age-Related Macular Degeneration
by: Yi-Ping Yang, et al.
Published: (2022-11-01)

Stem cell‐derived retinal pigment epithelium from patients with age‐related macular degeneration exhibit reduced metabolism and matrix interactions
by: Jie Gong, et al.
Published: (2020-03-01)

Lipofuscin and age-related macular degeneration
by: Mao-Mei Luo, et al.
Published: (2019-08-01)

Age-related macular degeneration: an overview
by: Rogil José de Almeida Torres, et al.
Published: (2021-10-01)

Research progress of stem cell-derived RPE cell transplantation therapy for retinal degenerative diseases
by: Tian-Yue Cao, et al.
Published: (2017-12-01)

Human-induced pluripotent stem cells-derived retinal pigmented epithelium, a new horizon for cells-based therapies for age-related macular degeneration
by: Samaneh Dehghan, et al.
Published: (2022-05-01)

Analysis of Retinol Binding Protein 4 and <i>ABCA4</i> Gene Variation in Non-Neovascular Age-Related Macular Degeneration
by: Hung-Da Chou, et al.
Published: (2023-07-01)

Cellular senescence in the aging retina and developments of senotherapies for age-related macular degeneration
by: Keng Siang Lee, et al.
Published: (2021-01-01)

Stem cell therapies for age-related macular degeneration: the past, present, and future
by: Dang Y, et al.
Published: (2015-01-01)

Autologous full-thickness RPE-choroid graft to treat high-risk drusenoid pigment epithelial detachment without CNV
by: Sillen, Hedwig, et al.
Published: (2020-04-01)

Inhibiting HIF-1 signaling alleviates HTRA1-induced RPE senescence in retinal degeneration
by: Wenchang Xu, et al.
Published: (2023-06-01)

Characterization of age-related macular degeneration in Indian donor eyes
by: Sudha Priya Soundara Pandi, et al.
Published: (2021-01-01)

Magnetic nanoparticles conjugated with “RPE cell -MCP-1 antibody -VEGF antibody” compounds for the targeted therapy of age-related macular degeneration: a hypothesis
by: Zhao-Jiang Du, et al.
Published: (2017-05-01)

Retinal pigment epithelium extracellular vesicles are potent inducers of age‐related macular degeneration disease phenotype in the outer retina
by: Marzena Kurzawa‐Akanbi, et al.
Published: (2022-12-01)

Chorioretinal thickness and retinal pigment epithelial degeneration of fellow eyes in patients with unilateral neovascular age-related macular degeneration with subretinal drusenoid deposits
by: Dongwan Kang, et al.
Published: (2022-07-01)

Age-Related Macular Degeneration and Mitochondria-Associated Autoantibodies: A Review of the Specific Pathogenesis and Therapeutic Strategies
by: Sichang Qu, et al.
Published: (2024-01-01)

Cytoprotective Potential of Fucoxanthin in Oxidative Stress-Induced Age-Related Macular Degeneration and Retinal Pigment Epithelial Cell Senescence In Vivo and In Vitro
by: Shiu-Jau Chen, et al.
Published: (2021-02-01)

The reduction of XIAP is associated with inflammasome activation in RPE: implications for AMD pathogenesis
by: Jiangyuan Gao, et al.
Published: (2019-08-01)